Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Depressive Disorder × Selective Serotonin Reuptake Inhibitors × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 1 Depressive Disorder 1

Interventions

Venlafaxine Hydrochloride 1 Specimen Handling 1 Selective Serotonin Reuptake Inhibitors 1 Psilocybin 1 Interviews as Topic 1 Dignity Therapy 1 Counseling 1 Antidepressive Agents, Tricyclic 1 Antidepressive Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01077596 2017-05-30

Carcinogenicity Study of Bupropion

GlaxoSmithKline

50,430 enrolled 23 charts

Depressive Disorder, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡